Report Code : CVMI2603252601431 | Published Date : March 30, 2025

1 | Market Overview
The global cholera vaccine market is experiencing significant growth, fueled by increasing demand for disease prevention in endemic regions, refugee camps, and disaster-prone areas. Cholera, caused by Vibrio cholerae, continues to be a major public health threat in low-income regions with poor water sanitation. Vaccines play a vital role in controlling outbreaks and reducing mortality.

Market growth is driven by increased World Health Organization (WHO) stockpile funding, government immunization programs, and the development of oral vaccines that are easier to distribute in resource-limited settings. Advances in single-dose and heat-stable formulations are further speeding up adoption.

 

2 | Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

0.27

Historical benchmark

2024

0.43

Five-year CAGR 9.7%

2031

1.02

Seven-year CAGR 12.8%

The market is projected to more than double by 2031, driven by expanded vaccination initiatives and public health investments.

 

3 | Key Market Drivers

  • Rising Cholera Incidence in Endemic Regions.
  • WHO and UNICEF Stockpile Programs for Outbreak Control.
  • Advancements in Oral, Heat-Stable, and Single-Dose Vaccines.
  • Growing Focus on Emergency Response in Disaster-Prone Areas.
  • Government and NGO Support for Mass Immunization Campaigns.

 

4 | Market Challenges

  • Limited Cold Chain Infrastructure in Remote Areas.
  • Vaccine Supply Constraints During Major Outbreaks.
  • Short Shelf-Life of Some Vaccine Formulations.
  • Low Awareness in Certain High-Risk Populations.

 

5 | Competitive Landscape

The cholera vaccine market is moderately consolidated with key manufacturers supplying both public and private sectors, primarily focused on oral vaccines.

Market Share Estimates (2024):

Company

Estimated Market Share

Key Products

EuBiologics Co., Ltd.

32%

Euvichol®, Euvichol-Plus®

Valneva SE

25%

Dukoral® (oral vaccine)

Shantha Biotechnics (Sanofi)

17%

Shanchol™ (oral vaccine)

Emergent BioSolutions

11%

Vaxchora® (single-dose traveler vaccine)

Others (Biological E, Indian Immunologicals, regional OEMs)

15%

Pipeline and local vaccines

 

6 | Market Segmentation
By Product Type:

  • Killed Oral Cholera Vaccines (OCVs)
  • Live Attenuated Oral Vaccines
  • Parenteral (Injectable) Vaccines (limited use)

 

By Application:

  • Outbreak Control
  • Traveler Immunization
  • Endemic Population Immunization
  • Military and Disaster Response

 

By End User:

  • Government & Public Health Agencies
  • NGOs & International Organizations (WHO, UNICEF)
  • Hospitals & Clinics
  • Traveler Health Clinics

 

By Region:

  • Africa
  • Asia-Pacific
  • Latin America
  • Middle East
  • North America & Europe (primarily travelers)

 

7 | Strategic Outlook
Investments in next-generation oral vaccines, expansion of WHO stockpiles, AI-driven outbreak prediction systems, and the development of single-dose, temperature-stable formulations will drive future growth in the cholera vaccine market. Demand in endemic regions will continue to drive market growth.





Reasons To Buy

Image



Scope

Image

Key Players

  • Valneva SE
  • Sanofi S.A. (including its Shantha Biotechnics subsidiary)
  • Emergent BioSolutions Inc.
  • PaxVax Inc.
  • EuBiologics Co., Ltd.
  • Hilleman Laboratories
  • Astellas Pharma Inc.
  • Incepta Vaccine Ltd.
  • Vabiotech
  • GlaxoSmithKline plc (GSK)
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson Services Inc.
  • Celldex Therapeutics Inc.
  • Bayerian Nordic A/S

 

Global Cholera Vaccine Market Report


  1. 1. Global Cholera Vaccine Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Cholera Vaccine Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Global Cholera Vaccine Market Research Report - Preface
    1. 2.1 Global Cholera Vaccine Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Product Type
      2. 2.1.2 By Application
      3. 2.1.3 By End User
      4. 2.1.4 By Region
  3. 3. Global Cholera Vaccine Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Product Type, By Application, By End User, By Country
    3. 3.3. Opportunities – By Product Type, By Application, By End User, By Country
    4. 3.4. Trends – By Product Type, By Application, By End User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Cholera Vaccine Market Research Report – DROTs Impact Analysis
    1. 4. Global Cholera Vaccine Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Global Cholera Vaccine Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Killed Oral Cholera Vaccines (OCVs)
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Live Attenuated Oral Vaccines
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Parenteral (Injectable) Vaccines (limited use)
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Cholera Vaccine Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Outbreak Control
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Traveler Immunization
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Endemic Population Immunization
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 6.4 Military and Disaster Response
    17. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Cholera Vaccine Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Government & Public Health Agencies
    2. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.2 NGOs & International Organizations (WHO, UNICEF)
    7. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 7.3 Hospitals & Clinics
    12. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 7.4 Traveler Health Clinics
    17. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 8. Global Cholera Vaccine Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.5 Middle East and Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.6 Global Cholera Vaccine Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Region, 2024 - 2031
  1. 9. North America Global Cholera Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Killed Oral Cholera Vaccines (OCVs)
      2. 9.1.2 Live Attenuated Oral Vaccines
      3. 9.1.3 Parenteral (Injectable) Vaccines (limited use)
      9.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Outbreak Control
      2. 9.2.2 Traveler Immunization
      3. 9.2.3 Endemic Population Immunization
      4. 9.2.4 Military and Disaster Response
      9.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Government & Public Health Agencies
      2. 9.3.2 NGOs & International Organizations (WHO, UNICEF)
      3. 9.3.3 Hospitals & Clinics
      4. 9.3.4 Traveler Health Clinics
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
    2. 9.5 North America Global Cholera Vaccine Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2024 - 2031
    3. 9.6 Regional Trends Analysis
    4. 9.7 North America Global Cholera Vaccine Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Global Cholera Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Killed Oral Cholera Vaccines (OCVs)
      2. 10.1.2 Live Attenuated Oral Vaccines
      3. 10.1.3 Parenteral (Injectable) Vaccines (limited use)
      10.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Outbreak Control
      2. 10.2.2 Traveler Immunization
      3. 10.2.3 Endemic Population Immunization
      4. 10.2.4 Military and Disaster Response
      10.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Government & Public Health Agencies
      2. 10.3.2 NGOs & International Organizations (WHO, UNICEF)
      3. 10.3.3 Hospitals & Clinics
      4. 10.3.4 Traveler Health Clinics
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands and Rest of Europe
    2. 10.5 Europe Global Cholera Vaccine Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2024 - 2031
    3. 10.6 Regional Trends Analysis
    4. 10.7 Europe Global Cholera Vaccine Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Global Cholera Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Killed Oral Cholera Vaccines (OCVs)
      2. 11.1.2 Live Attenuated Oral Vaccines
      3. 11.1.3 Parenteral (Injectable) Vaccines (limited use)
      11.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Outbreak Control
      2. 11.2.2 Traveler Immunization
      3. 11.2.3 Endemic Population Immunization
      4. 11.2.4 Military and Disaster Response
      11.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Government & Public Health Agencies
      2. 11.3.2 NGOs & International Organizations (WHO, UNICEF)
      3. 11.3.3 Hospitals & Clinics
      4. 11.3.4 Traveler Health Clinics
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & New Zealand
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
    2. 11.5 Asia-Pacific Global Cholera Vaccine Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2024 - 2031
    3. 11.6 Regional Trends Analysis
    4. 11.7 Asia-Pacific Global Cholera Vaccine Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Global Cholera Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Killed Oral Cholera Vaccines (OCVs)
      2. 12.1.2 Live Attenuated Oral Vaccines
      3. 12.1.3 Parenteral (Injectable) Vaccines (limited use)
      12.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Outbreak Control
      2. 12.2.2 Traveler Immunization
      3. 12.2.3 Endemic Population Immunization
      4. 12.2.4 Military and Disaster Response
      12.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Government & Public Health Agencies
      2. 12.3.2 NGOs & International Organizations (WHO, UNICEF)
      3. 12.3.3 Hospitals & Clinics
      4. 12.3.4 Traveler Health Clinics
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
    2. 12.5 Latin America Global Cholera Vaccine Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2024 - 2031
    3. 12.6 Regional Trends Analysis
    4. 12.7 Latin America Global Cholera Vaccine Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East and Africa Global Cholera Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Killed Oral Cholera Vaccines (OCVs)
      2. 13.1.2 Live Attenuated Oral Vaccines
      3. 13.1.3 Parenteral (Injectable) Vaccines (limited use)
      13.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Outbreak Control
      2. 13.2.2 Traveler Immunization
      3. 13.2.3 Endemic Population Immunization
      4. 13.2.4 Military and Disaster Response
      13.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Government & Public Health Agencies
      2. 13.3.2 NGOs & International Organizations (WHO, UNICEF)
      3. 13.3.3 Hospitals & Clinics
      4. 13.3.4 Traveler Health Clinics
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 Qatar
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
    2. 13.5 Middle East and Africa Global Cholera Vaccine Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2024 - 2031
    3. 13.6 Regional Trends Analysis
    4. 13.7 Middle East and Africa Global Cholera Vaccine Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
    2. 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Valneva SE
      2. 14.2.2 Sanofi S.A. (including its Shantha Biotechnics subsidiary)
      3. 14.2.3 Emergent BioSolutions Inc.
      4. 14.2.4 PaxVax Inc.
      5. 14.2.5 EuBiologics Co. Ltd.
      6. 14.2.6 Hilleman Laboratories
      7. 14.2.7 Astellas Pharma Inc.
      8. 14.2.8 Incepta Vaccine Ltd.
      9. 14.2.9 Vabiotech
      10. 14.2.10 GlaxoSmithKline plc (GSK)
      11. 14.2.11 Pfizer Inc.
      12. 14.2.12 Merck & Co. Inc.
      13. 14.2.13 Johnson & Johnson Services Inc.
      14. 14.2.14 Celldex Therapeutics Inc.
      15. 14.2.15 Bayerian Nordic A/S
  1. 15. Data Collection Method and Research Approach
  2. 16. Principal Presumptions and Acronyms